Skip to main content
SpringerLink
Log in

Obesity and Colorectal Cancer

  • Chapter
  • First Online:
Obesity and Cancer

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 208))

Abstract

There is strong evidence that modifiable lifestyle factors such as obesity play a key role in colorectal carcinogenesis. Epidemiologic data have consistently reported a positive association between obesity and colorectal cancer. The relative risk associated with general obesity (as assessed by BMI) is higher in men than in women and for cancer of the colon than for cancer of the rectum. Abdominal obesity (as assessed by waist circumference (WC) or waist-to-hip ratio) is associated with an increased risk of colorectal cancer in both sexes, with stronger associations for cancer of the colon than for cancer of the rectum. Plausible biological mechanisms include insulin resistance, hyperinsulinemia, chronic inflammation, altered levels of growth factors, adipocytokines and steroid hormones. In addition to its effect on colorectal cancer incidence, obesity may play a role in colorectal cancer recurrence, treatment outcomes and survival. Understanding the effects of childhood and adolescent obesity and weight change over the life course in relation to future risk of colorectal cancer is incomplete but essential for targeted preventive recommendations. This chapter summarizes the current evidence on the relationship between obesity and colorectal cancer and colorectal adenoma, a common precursor lesion.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    Following lung cancer and prostate cancer.

  2. 2.

    Following breast cancer.

  3. 3.

    Following death from cancer of the lung, liver and stomach.

  4. 4.

    Defined as an increase in waist circumference (WC) or waist-to-hip ratio (WHR).

  5. 5.

    Defined as a body mass index (BMI) ≥ 30 kg/m².

References

  1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386. doi:10.1002/ijc.29210

    Article  CAS  PubMed  Google Scholar 

  2. Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, Forman D, Bray F (2012) Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet 380(9856):1840–1850. doi:10.1016/s0140-6736(12)60919-2

    Article  PubMed  Google Scholar 

  3. Flood DM, Weiss NS, Cook LS, Emerson JC, Schwartz SM, Potter JD (2000) Colorectal cancer incidence in Asian migrants to the United States and their descendants. Cancer Causes Control (CCC) 11(5):403–411

    Article  CAS  Google Scholar 

  4. Sung JJ, Lau JY, Goh KL, Leung WK (2005) Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol 6(11):871–876. doi:10.1016/s1470-2045(05)70422-8

    Article  PubMed  Google Scholar 

  5. World Cancer Research Fund/American Institute for Cancer Research (2011) Continuous update project report: colorectal cancer 2011 report—food, nutrition, physical activity, and the prevention of colorectal cancer

    Google Scholar 

  6. Johnson CM, Wei C, Ensor JE, Smolenski DJ, Amos CI, Levin B, Berry DA (2013) Meta-analyses of colorectal cancer risk factors. Cancer Causes Control (CCC) 24(6):1207–1222. doi:10.1007/s10552-013-0201-5

    Article  Google Scholar 

  7. Weitz J, Koch M, Debus J, Hohler T, Galle PR, Buchler MW (2005) Colorectal cancer. Lancet 365(9454):153–165. doi:10.1016/s0140-6736(05)17706-x

    Article  PubMed  Google Scholar 

  8. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61(5):759–767

    Article  CAS  PubMed  Google Scholar 

  9. Brenner H, Hoffmeister M, Stegmaier C, Brenner G, Altenhofen L, Haug U (2007) Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies. Gut 56(11):1585–1589. doi:10.1136/gut.2007.122739

    Article  PubMed  PubMed Central  Google Scholar 

  10. Bergstrom A, Pisani P, Tenet V, Wolk A, Adami HO (2001) Overweight as an avoidable cause of cancer in Europe. Int J Cancer J Int Cancer 91(3):421–430

    Article  CAS  Google Scholar 

  11. World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. World Cancer Research Fund, American Institute for Cancer Research, Washington DC

    Google Scholar 

  12. Ma Y, Yang Y, Wang F, Zhang P, Shi C, Zou Y, Qin H (2013) Obesity and risk of colorectal cancer: a systematic review of prospective studies. PLoS ONE 8(1):e53916. doi:10.1371/journal.pone.0053916

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Matsuo K, Mizoue T, Tanaka K, Tsuji I, Sugawara Y, Sasazuki S, Nagata C, Tamakoshi A, Wakai K, Inoue M, Tsugane S (2012) Association between body mass index and the colorectal cancer risk in Japan: pooled analysis of population-based cohort studies in Japan. Ann Oncol (Official Journal of the European Society for Medical Oncology/ESMO) 23(2):479–490. doi:10.1093/annonc/mdr143

    Article  CAS  Google Scholar 

  14. Lee YJ, Myung SK, Cho B, Park BJ, Park JH, Ju W, Park MS, Choi JH (2011) Adiposity and the risk of colorectal adenomatous polyps: a meta-analysis. Cancer Causes Control (CCC) 22(7):1021–1035. doi:10.1007/s10552-011-9777-9

    Article  Google Scholar 

  15. Okabayashi K, Ashrafian H, Hasegawa H, Yoo JH, Patel VM, Harling L, Rowland SP, Ali M, Kitagawa Y, Darzi A, Athanasiou T (2012) Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis. Am J Gastroenterol 107(8):1175–1185; quiz 1186. doi:10.1038/ajg.2012.180

    Google Scholar 

  16. Omata F, Deshpande GA, Ohde S, Mine T, Fukui T (2013) The association between obesity and colorectal adenoma: systematic review and meta-analysis. Scand J Gastroenterol 48(2):136–146. doi:10.3109/00365521.2012.737364

    Article  PubMed  Google Scholar 

  17. Ben Q, An W, Jiang Y, Zhan X, Du Y, Cai QC, Gao J, Li Z (2012) Body mass index increases risk for colorectal adenomas based on meta-analysis. Gastroenterology 142(4):762–772. doi:10.1053/j.gastro.2011.12.050

    Article  PubMed  Google Scholar 

  18. Moghaddam AA, Woodward M, Huxley R (2007) Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomark Prev 16(12):2533–2547

    Article  Google Scholar 

  19. Dai Z, Xu YC, Niu L (2007) Obesity and colorectal cancer risk: a meta-analysis of cohort studies. World J Gastroenterol (WJG) 13(31):4199–4206

    Article  Google Scholar 

  20. Larsson SC, Wolk A (2007) Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 86(3):556–565

    CAS  PubMed  Google Scholar 

  21. Hong S, Cai Q, Chen D, Zhu W, Huang W, Li Z (2012) Abdominal obesity and the risk of colorectal adenoma: a meta-analysis of observational studies. Eur J Cancer Prev [The Official Journal of the European Cancer Prevention Organisation (ECP)] 21(6):523–531. doi:10.1097/CEJ.0b013e328351c775

    Article  Google Scholar 

  22. National Cancer Institute (2012) SEER stat fact sheets: colon and rectum cancer. http://seer.cancer.gov/statfacts/html/colorect.html. Accessed 01 Sept 2015

  23. Lee J, Meyerhardt JA, Giovannucci E, Jeon JY (2015) Association between body mass index and prognosis of colorectal cancer: a meta-analysis of prospective cohort studies. PLoS ONE 10(3):e0120706. doi:10.1371/journal.pone.0120706

    Article  PubMed  PubMed Central  Google Scholar 

  24. Vrieling A, Kampman E (2010) The role of body mass index, physical activity, and diet in colorectal cancer recurrence and survival: a review of the literature. Am J Clin Nutr 92(3):471–490. doi:10.3945/ajcn.2010.29005

    Article  CAS  PubMed  Google Scholar 

  25. Parkin E, O’Reilly DA, Sherlock DJ, Manoharan P, Renehan AG (2014) Excess adiposity and survival in patients with colorectal cancer: a systematic review. Obesity Rev (An Official Journal of the International Association for the Study of Obesity) 15(5):434–451. doi:10.1111/obr.12140

    Article  Google Scholar 

  26. Haydon AM, Macinnis RJ, English DR, Giles GG (2006) Effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut 55(1):62–67. doi:10.1136/gut.2005.068189

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Prizment AE, Flood A, Anderson KE, Folsom AR (2010) Survival of women with colon cancer in relation to precancer anthropometric characteristics: the Iowa Women’s Health Study. Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology) 19(9):2229–2237. doi:10.1158/1055-9965.epi-10-0522

    Article  Google Scholar 

  28. Moon HG, Ju YT, Jeong CY, Jung EJ, Lee YJ, Hong SC, Ha WS, Park ST, Choi SK (2008) Visceral obesity may affect oncologic outcome in patients with colorectal cancer. Ann Surg Oncol 15(7):1918–1922. doi:10.1245/s10434-008-9891-4

    Article  PubMed  Google Scholar 

  29. Amri R, Bordeianou LG, Sylla P, Berger DL (2014) Obesity, outcomes and quality of care: body mass index increases the risk of wound-related complications in colon cancer surgery. Am J Surg 207(1):17–23. doi:10.1016/j.amjsurg.2013.05.016

    Article  PubMed  Google Scholar 

  30. Aytac E, Lavery IC, Kalady MF, Kiran RP (2013) Impact of obesity on operation performed, complications, and long-term outcomes in terms of restoration of intestinal continuity for patients with mid and low rectal cancer. Dis Colon Rectum 56(6):689–697. doi:10.1097/DCR.0b013e3182880ffa

    Article  PubMed  Google Scholar 

  31. Zhou Y, Wu L, Li X, Wu X, Li B (2012) Outcome of laparoscopic colorectal surgery in obese and nonobese patients: a meta-analysis. Surg Endosc 26(3):783–789. doi:10.1007/s00464-011-1952-2

    Article  PubMed  Google Scholar 

  32. Faruk Aykan N, Yildiz I, Sen F, Kilic L, Keskin S, Ciftci R, Karabulut S, Sakar B, Disci R (2013) Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy. Med Oncol (Northwood, London, England) 30(3):679. doi:10.1007/s12032-013-0679-4

  33. Sellar CM, Courneya KS (2011) Physical activity and gastrointestinal cancer survivorship. In: Courneya KS, Friedenreich CM (eds) Physical activity and cancer. Springer, Berlin

    Google Scholar 

  34. Schlesinger S, Lieb W, Koch M, Fedirko V, Dahm CC, Pischon T, Nothlings U, Boeing H, Aleksandrova K (2015) Body weight gain and risk of colorectal cancer: a systematic review and meta-analysis of observational studies. Obesity Rev (An Official Journal of the International Association for the Study of Obesity) 16(7):607–619. doi:10.1111/obr.12286

    Article  CAS  Google Scholar 

  35. Chen Q, Wang J, Yang J, Jin Z, Shi W, Qin Y, Yu F, He J (2015) Association between adult weight gain and colorectal cancer: a dose-response meta-analysis of observational studies. Int J Cancer J Int Cancer 136(12):2880–2889. doi:10.1002/ijc.29331

    Article  CAS  Google Scholar 

  36. Karahalios A, English DR, Simpson JA (2015) Weight change and risk of colorectal cancer: a systematic review and meta-analysis. Am J Epidemiol 181(11):832–845. doi:10.1093/aje/kwu357

    Article  PubMed  Google Scholar 

  37. Keum N, Greenwood DC, Lee DH, Kim R, Aune D, Ju W, Hu FB, Giovannucci EL (2015) Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies. J Natl Cancer Inst 107(2). doi:10.1093/jnci/djv088

  38. Yang XW, Li PZ, Zhu LY, Zhu S (2015) Effects of bariatric surgery on incidence of obesity-related cancers: a meta-analysis. Med Sci Monit (International Medical Journal of Experimental and Clinical Research) 21:1350–1357. doi:10.12659/msm.893553

    Google Scholar 

  39. Afshar S, Kelly SB, Seymour K, Lara J, Woodcock S, Mathers JC (2014) The effects of bariatric surgery on colorectal cancer risk: systematic review and meta-analysis. Obes Surg 24(10):1793–1799. doi:10.1007/s11695-014-1359-y

    Article  PubMed  Google Scholar 

  40. Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA (2014) The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003–2012. JAMA surgery 149(3):275–287. doi:10.1001/jamasurg.2013.3654

    Article  PubMed  PubMed Central  Google Scholar 

  41. Nimptsch K, Giovannucci E, Willett WC, Fuchs CS, Wei EK, Wu K (2011) Body fatness during childhood and adolescence, adult height, and risk of colorectal adenoma in women. Cancer Prev Res 4(10):1710–1718. doi:10.1158/1940-6207.CAPR-11-0272

    Google Scholar 

  42. Zhang X, Wu K, Giovannucci EL, Ma J, Colditz GA, Fuchs CS, Willett WC, Stampfer MJ, Nimptsch K, Ogino S, Wei EK (2015) Early life body fatness and risk of colorectal cancer in US Women and men-results from two large cohort studies. Cancer Epidemiol Biomark Prev 24(4):690–697. doi:10.1158/1055-9965.EPI-14-0909-T

    Article  CAS  Google Scholar 

  43. Levi Z, Kark JD, Barchana M, Liphshitz I, Zavdi O, Tzur D, Derazne E, Furman M, Niv Y, Gordon B, Afek A, Shamiss A (2011) Measured body mass index in adolescence and the incidence of colorectal cancer in a cohort of 1.1 million males. Cancer epidemiology, biomarkers and prevention: a publication of the American association for cancer research, cosponsored by the American society of preventive. Oncology 20(12):2524–2531. doi:10.1158/1055-9965.epi-11-0531

    Google Scholar 

  44. Bjorge T, Engeland A, Tverdal A, Smith GD (2008) Body mass index in adolescence in relation to cause-specific mortality: a follow-up of 230,000 Norwegian adolescents. Am J Epidemiol 168(1):30–37

    Article  PubMed  Google Scholar 

  45. Gray L, Lee IM, Sesso HD, Batty GD (2012) Association of body mass index in early adulthood and middle age with future site-specific cancer mortality: the Harvard Alumni Health Study. Ann Oncol (Official Journal of the European Society for Medical Oncology/ESMO) 23(3):754–759. doi:10.1093/annonc/mdr270

    Article  CAS  Google Scholar 

  46. Han X, Stevens J, Truesdale KP, Bradshaw PT, Kucharska-Newton A, Prizment AE, Platz EA, Joshu CE (2014) Body mass index at early adulthood, subsequent weight change and cancer incidence and mortality. Int J Cancer J Int Cancer 135(12):2900–2909. doi:10.1002/ijc.28930

    Article  CAS  Google Scholar 

  47. Guilherme A, Virbasius JV, Puri V, Czech MP (2008) Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9(5):367–377. doi:10.1038/nrm2391

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Boden G, Chen X, Ruiz J, White JV, Rossetti L (1994) Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Investig 93(6):2438–2446. doi:10.1172/jci117252

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev 4(8):579–591. doi:10.1038/nrc1408

    Article  CAS  Google Scholar 

  50. Guo YS, Narayan S, Yallampalli C, Singh P (1992) Characterization of insulinlike growth factor I receptors in human colon cancer. Gastroenterology 102(4 Pt 1):1101–1108

    Article  CAS  PubMed  Google Scholar 

  51. Guraya SY (2015) Association of type 2 diabetes mellitus and the risk of colorectal cancer: a meta-analysis and systematic review. World J Gastroenterol (WJG) 21(19):6026–6031. doi:10.3748/wjg.v21.i19.6026

    CAS  Google Scholar 

  52. Renehan AG, O’Connell J, O’Halloran D, Shanahan F, Potten CS, O’Dwyer ST, Shalet SM (2003) Acromegaly and colorectal cancer: a comprehensive review of epidemiology, biological mechanisms, and clinical implications. Horm Metab Res = Hormon- und Stoffwechselforschung = Hormones et metabolisme 35(11–12):712–725. doi:10.1055/s-2004-814150

  53. Rinaldi S, Cleveland R, Norat T, Biessy C, Rohrmann S, Linseisen J, Boeing H, Pischon T, Panico S, Agnoli C, Palli D, Tumino R, Vineis P, Peeters PH, van Gils CH, Bueno-de-Mesquita BH, Vrieling A, Allen NE, Roddam A, Bingham S, Khaw KT, Manjer J, Borgquist S, Dumeaux V, Torhild Gram I, Lund E, Trichopoulou A, Makrygiannis G, Benetou V, Molina E, Donate Suarez I, Barricarte Gurrea A, Gonzalez CA, Tormo MJ, Altzibar JM, Olsen A, Tjonneland A, Gronbaek H, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Morois S, Slimani N, Boffetta P, Jenab M, Riboli E, Kaaks R (2010) Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies. Int J Cancer 126(7):1702–1715

    CAS  PubMed  Google Scholar 

  54. Chen L, Li L, Wang Y, Li P, Luo L, Yang B, Wang H, Chen M (2013) Circulating C-peptide level is a predictive factor for colorectal neoplasia: evidence from the meta-analysis of prospective studies. Cancer Causes Control (CCC) 24(10):1837–1847. doi:10.1007/s10552-013-0261-6

    Article  CAS  Google Scholar 

  55. Chi F, Wu R, Zeng YC, Xing R, Liu Y (2013) Circulation insulin-like growth factor peptides and colorectal cancer risk: an updated systematic review and meta-analysis. Mol Biol Rep 40(5):3583–3590. doi:10.1007/s11033-012-2432-z

    Article  CAS  PubMed  Google Scholar 

  56. Yoon YS, Keum N, Zhang X, Cho E, Giovannucci EL (2015) Hyperinsulinemia, insulin resistance and colorectal adenomas: a meta-analysis. Metabolism (Clinical And Experimental). doi:10.1016/j.metabol.2015.06.013

    Google Scholar 

  57. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Investig 112(12):1796–1808. doi:10.1172/jci19246

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Roberts DL, Dive C, Renehan AG (2010) Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med 61:301–316. doi:10.1146/annurev.med.080708.082713

    Article  CAS  PubMed  Google Scholar 

  59. Liu Z, Brooks RS, Ciappio ED, Kim SJ, Crott JW, Bennett G, Greenberg AS, Mason JB (2012) Diet-induced obesity elevates colonic TNF-alpha in mice and is accompanied by an activation of Wnt signaling: a mechanism for obesity-associated colorectal cancer. J Nutr Biochem 23(10):1207–1213. doi:10.1016/j.jnutbio.2011.07.002

    Article  CAS  PubMed  Google Scholar 

  60. Choi J, Joseph L, Pilote L (2013) Obesity and C-reactive protein in various populations: a systematic review and meta-analysis. Obesity Rev (An Official Journal of the International Association for the Study of Obesity) 14(3):232–244. doi:10.1111/obr.12003

    Article  CAS  Google Scholar 

  61. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW (1999) C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19(4):972–978

    Google Scholar 

  62. Tsilidis KK, Branchini C, Guallar E, Helzlsouer KJ, Erlinger TP, Platz EA (2008) C-reactive protein and colorectal cancer risk: a systematic review of prospective studies. Int J Cancer 123(5):1133–1140. doi:10.1002/ijc.23606

    Article  CAS  PubMed  Google Scholar 

  63. Knupfer H, Preiss R (2010) Serum interleukin-6 levels in colorectal cancer patients–a summary of published results. Int J Colorectal Dis 25(2):135–140. doi:10.1007/s00384-009-0818-8

    Article  PubMed  Google Scholar 

  64. Castano-Milla C, Chaparro M, Gisbert JP (2014) Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis. Aliment Pharmacol Ther 39(7):645–659. doi:10.1111/apt.12651

    Article  CAS  PubMed  Google Scholar 

  65. Laukoetter MG, Mennigen R, Hannig CM, Osada N, Rijcken E, Vowinkel T, Krieglstein CF, Senninger N, Anthoni C, Bruewer M (2011) Intestinal cancer risk in Crohn’s disease: a meta-analysis. J Gastrointest Surg (Official Journal of the Society for Surgery of the Alimentary Tract) 15(4):576–583. doi:10.1007/s11605-010-1402-9

    Article  Google Scholar 

  66. Canavan C, Abrams KR, Mayberry J (2006) Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn’s disease. Aliment Pharmacol Ther 23(8):1097–1104. doi:10.1111/j.1365-2036.2006.02854.x

    Article  CAS  PubMed  Google Scholar 

  67. Ye X, Fu J, Yang Y, Chen S (2013) Dose-risk and duration-risk relationships between aspirin and colorectal cancer: a meta-analysis of published cohort studies. PLoS ONE 8(2):e57578. doi:10.1371/journal.pone.0057578

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Nagaraju GP, Aliya S, Alese OB (2015) Role of adiponectin in obesity related gastrointestinal carcinogenesis. Cytokine Growth Factor Rev 26(1):83–93. doi:10.1016/j.cytogfr.2014.06.007

    Article  CAS  PubMed  Google Scholar 

  69. De Rosa A, Monaco ML, Capasso M, Forestieri P, Pilone V, Nardelli C, Buono P, Daniele A (2013) Adiponectin oligomers as potential indicators of adipose tissue improvement in obese subjects. Eur J Endocrinol/Eur Fed Endocr Soc 169(1):37–43. doi:10.1530/eje-12-1039

    Article  Google Scholar 

  70. Moon HS, Liu X, Nagel JM, Chamberland JP, Diakopoulos KN, Brinkoetter MT, Hatziapostolou M, Wu Y, Robson SC, Iliopoulos D, Mantzoros CS (2013) Salutary effects of adiponectin on colon cancer: in vivo and in vitro studies in mice. Gut 62(4):561–570. doi:10.1136/gutjnl-2012-302092

    Article  CAS  PubMed  Google Scholar 

  71. Joshi RK, Kim WJ, Lee SA (2014) Association between obesity-related adipokines and colorectal cancer: a case-control study and meta-analysis. World J Gastroenterol (WJG) 20(24):7941–7949. doi:10.3748/wjg.v20.i24.7941

    Article  Google Scholar 

  72. An W, Bai Y, Deng SX, Gao J, Ben QW, Cai QC, Zhang HG, Li ZS (2012) Adiponectin levels in patients with colorectal cancer and adenoma: a meta-analysis. Eur J Cancer Prev 21(2):126–133. doi:10.1097/CEJ.0b013e32834c9b55

    Article  CAS  PubMed  Google Scholar 

  73. Xu XT, Xu Q, Tong JL, Zhu MM, Huang ML, Ran ZH, Xiao SD (2011) Meta-analysis: circulating adiponectin levels and risk of colorectal cancer and adenoma. J Dig Dis 12(4):234–244. doi:10.1111/j.1751-2980.2011.00504.x

    Article  CAS  PubMed  Google Scholar 

  74. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372(6505):425–432. doi:10.1038/372425a0

    Article  CAS  PubMed  Google Scholar 

  75. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL et al (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334(5):292–295. doi:10.1056/nejm199602013340503

    Article  CAS  PubMed  Google Scholar 

  76. Kelesidis T, Kelesidis I, Chou S, Mantzoros CS (2010) Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med 152(2):93–100. doi:10.7326/0003-4819-152-2-201001190-00008

    Article  PubMed  PubMed Central  Google Scholar 

  77. Hardwick JC, Van Den Brink GR, Offerhaus GJ, Van Deventer SJ, Peppelenbosch MP (2001) Leptin is a growth factor for colonic epithelial cells. Gastroenterology 121(1):79–90

    Article  CAS  PubMed  Google Scholar 

  78. Gialamas SP, Sergentanis TN, Antonopoulos CN, Dessypris N, Chrousos GP, Petridou ET (2013) Circulating leptin levels and risk of colorectal cancer and adenoma: a case-control study and meta-analysis. Cancer Causes Control (CCC) 24(12):2129–2141. doi:10.1007/s10552-013-0290-1

    Article  Google Scholar 

  79. Murphy N, Strickler HD, Stanczyk FZ, Xue X, Wassertheil-Smoller S, Rohan TE, Ho GY, Anderson GL, Potter JD, Gunter MJ (2015) A prospective evaluation of endogenous sex hormone levels and colorectal cancer risk in postmenopausal women. J Natl Cancer Inst 107(10). doi:10.1093/jnci/djv210

    Google Scholar 

  80. Falk RT, Dallal CM, Lacey JV Jr, Bauer DC, Buist DS, Cauley JA, Hue TF, LaCroix AZ, Tice JA, Pfeiffer RM, Xu X, Veenstra TD, Brinton LA (2015) Estrogen metabolites are not associated with colorectal cancer risk in postmenopausal women. Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology) 24(9):1419–1422. doi:10.1158/1055-9965.epi-15-0541

    Article  CAS  Google Scholar 

  81. Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Howard BV, Wylie-Rosett J, Anderson GL, Ho GY, Kaplan RC, Li J, Xue X, Harris TG, Burk RD, Strickler HD (2008) Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer Res 68(1):329–337

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, Hubbell FA, Ascensao J, Rodabough RJ, Rosenberg CA, Taylor VM, Harris R, Chen C, Adams-Campbell LL, White E (2004) Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 350(10):991–1004. doi:10.1056/NEJMoa032071

    Article  CAS  PubMed  Google Scholar 

  83. Lin KJ, Cheung WY, Lai JY, Giovannucci EL (2012) The effect of estrogen versus combined estrogen-progestogen therapy on the risk of colorectal cancer. Int J Cancer J Int Cancer 130(2):419–430. doi:10.1002/ijc.26026

    Google Scholar 

  84. International Agency for Research on Cancer (2012) GLOBOCAN: colorectum—estimated incidence, all ages: both sexes. IARC. http://globocan.iarc.fr/old/summary_table_site-html.asp?selection=5060&title=Colorectum&sex=0&type=0&window=1&africa=1&america=2&asia=3&europe=4&oceania=5&build=6&sort=0&submit=%C2%A0Execute%C2%A0. Accessed 15 Aug 2015

  85. World Health Organization (2011) Noncommunicable diseases country profiles 2011. World Health Organization, Geneva

    Google Scholar 

  86. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371(9612):569–578. doi:10.1016/S0140-6736(08)60269-X

    Article  PubMed  Google Scholar 

  87. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH (2009) The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC public health 9:88. doi:10.1186/1471-2458-9-88

    Article  PubMed  PubMed Central  Google Scholar 

  88. Harriss DJ, Atkinson G, George K, Cable NT, Reilly T, Haboubi N, Zwahlen M, Egger M, Renehan AG (2009) Lifestyle factors and colorectal cancer risk (1): systematic review and meta-analysis of associations with body mass index. Colorectal Dis 11(6):547–563

    Article  CAS  PubMed  Google Scholar 

  89. Ning Y, Wang L, Giovannucci EL (2010) A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies. Obes Rev 11(1):19–30

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany

    Carmen Jochem & Michael Leitzmann

Authors
  1. Carmen Jochem
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Leitzmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Leitzmann .

Editor information

Editors and Affiliations

  1. Molecular Epidemiology Research Group, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Robert-Rössle-Straße , Berlin, Germany

    Tobias Pischon

  2. Molecular Epidemiology Research Group, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Robert-Rössle-Straße, Berlin, Germany

    Katharina Nimptsch

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Jochem, C., Leitzmann, M. (2016). Obesity and Colorectal Cancer. In: Pischon, T., Nimptsch, K. (eds) Obesity and Cancer. Recent Results in Cancer Research, vol 208. Springer, Cham. https://doi.org/10.1007/978-3-319-42542-9_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-42542-9_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-42540-5

  • Online ISBN: 978-3-319-42542-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation